BackApplied BioCode Overview

Applied BioCode Current Cash

Track Applied BioCode's current cash ($450M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$449.17M
↓ 9.43% YoYΔ $-46.74M vs prior year quarter

Peer trimmed avg / median

Loading

Applied BioCode Current Cash History

Loading

Applied BioCode vs. peers: Current Cash Comparison

Loading

Applied BioCode Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Applied BioCode (6598.TW) FAQ

The latest current cash for 6598.TW is $450M as of June 2026. That compares with $500M in the prior-year period — down 9.4% year over year. Investors often review this figure alongside Applied BioCode's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6598.TW's current cash moved from $500M to $450M — a 9.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Applied BioCode's operating scale or balance-sheet position.

A current cash figure of $450M for 6598.TW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6598.TW's current cash ($450M), review year-over-year change from $500M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.